Clinical and Molecular Spectrum of Muscular Dystrophies (MDs) with Intellectual Disability (ID): a Comprehensive Overview

J Mol Neurosci. 2022 Jan;72(1):9-23. doi: 10.1007/s12031-021-01933-4. Epub 2021 Nov 2.

Abstract

Muscular dystrophies encompass a wide and heterogeneous subset of hereditary myopathies that manifest by the structural or functional abnormalities in the skeletal muscle. Some pathogenic mutations induce a dysfunction or loss of proteins that are critical for the stability of muscle cells, leading to progressive muscle degradation and weakening. Several studies have well-established cognitive deficits in muscular dystrophies which are mainly due to the disruption of brain-specific expression of affected muscle proteins. We provide a comprehensive overview of the types of muscular dystrophies that are accompanied by intellectual disability by detailed consulting of the main libraries. The current paper focuses on the clinical and molecular evidence about Duchenne, congenital, limb-girdle, and facioscapulohumeral muscular dystrophies as well as myotonic dystrophies. Because these syndromes impose a heavy burden of psychological and financial problems on patients, their families, and the health care community, a thorough examination is necessary to perform timely psychological and medical interventions and thus improve the quality of life.

Keywords: CMD; DMD; FSHD; Intellectual disability; LGMD; Muscular dystrophy.

Publication types

  • Review

MeSH terms

  • Brain
  • Humans
  • Intellectual Disability* / genetics
  • Muscle, Skeletal
  • Muscular Dystrophies, Limb-Girdle* / genetics
  • Muscular Dystrophy, Duchenne*
  • Quality of Life